TOP 10 Number of people with diabetes (20-79 years), 2010 and 2030

IDF Regions and global projections for the number of people with diabetes (20-79 years),

FIGURE 1.1 The major diabetes complications

FIGURE 1.2 Insulin production and action

AT A GLANCE World

TOP 10 Prevalence (%) of diabetes(20-79 years), 2010 and 2030

FIGURE 2.1 Prevalence (%) estimates of diabetes (20-79 years) by region, 2010 and 2030

FIGURE 2.2 Number of people with diabetes by age group, 2010 and 2030

MAP 2.1 Prevalence (%) estimates of diabetes (20-79 years), 2010

MAP 2.2 Prevalence (%) estimates of diabetes (20-79 years), 2030

FIGURE 2.3 Number of people with impaired glucose tolerance by age group, 2010 and 2030

TOP 10 Prevalence (%) of impaired glucose tolerance (20-79 years), 2010 and 2030

MAP 2.3 Prevalence (%) estimates of impaired glucose tolerance (20-79 years), 2010

FIGURE 2.4 Estimated number of prevalent cases of type 1 diabetes in children, 0-14 years, by region, 2010

MAP 2.4 New cases of type 1 diabetes in children, 0-14 years (cases per 100,000 aged 0-14 years per year), 2010

FIGURE 2.5 Effect of depression on all-cause mortality in people with diabetes

FIGURE 2.6 Summary of prevalence (%) ranges of diabetes complications (all diabetes) found in different studies

FIGURE 2.7 Deaths attributable to diabetes as percentage of all deaths (20-79 years) by region, 2010

MAP 2.5 Number of deaths attributable to diabetes (20-79 years), 2010

MAP 2.6 Mean health expenditure per person with diabetes (USD), R=2, 2010

TABLE 3.1 Regional estimates for diabetes (20-79 years), 2010 and 2030

AT A GLANCE African Region

MAP 3.1 Prevalence (%) estimates of diabetes (20-79 years), 2010 African Region

FIGURE 3.1 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, African Region

AT A GLANCE European Region

MAP 3.2 Prevalence (%) estimates of diabetes (20-79 years), 2010 European Region

FIGURE 3.2 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, European Region

AT A GLANCE Middle East and North African Region

MAP 3.3 Prevalence (%) estimates of diabetes (20-79 years), 2010 Middle East and North African Region

FIGURE 3.3 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, Middle East and North African Region

AT A GLANCE North America and Caribbean Region

MAP 3.4 Prevalence (%) estimates of diabetes (20-79 years), 2010 North America and Caribbean Region

FIGURE 3.4 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, North America and Caribbean Region

AT A GLANCE South and Central American Region

MAP 3.5 Prevalence (%) estimates of diabetes (20-79 years), 2010 South and Central American Region

FIGURE 3.5 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, South and Central American Region

AT A GLANCE South-East Asian Region

MAP 3.6 Prevalence (%) estimates of diabetes (20-79 years), 2010 South-East Asian Region

FIGURE 3.6 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, South-East Asian Region

AT A GLANCE Western Pacific Region

MAP 3.7 Prevalence (%) estimates of diabetes (20-79 years), 2010 Western Pacific Region

FIGURE 3.7 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, Western Pacific Region

FIGURE 4.1 Perceived barriers to diabetes education

MAP 5.1 National Diabetes Programmes (NDP)

FIGURE 5.1 Affordability and availability of insulin

TABLE 5.1 Cost of diabetes care

FIGURE 6.1 Likelihood and severity of risks to global development